322 related articles for article (PubMed ID: 31002407)
21. Inflammation on bronchoalveolar lavage cytology is associated with decreased chronic lung allograft dysfunction-free survival.
Greenland NY; Deiter F; Calabrese DR; Hays SR; Kukreja J; Leard LE; Kolaitis NA; Golden JA; Singer JP; Greenland JR
Clin Transplant; 2022 Jun; 36(6):e14639. PubMed ID: 35246990
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
[TBL] [Abstract][Full Text] [Related]
23. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S
J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441
[TBL] [Abstract][Full Text] [Related]
24. BAL Fluid Eosinophilia Associates With Chronic Lung Allograft Dysfunction Risk: A Multicenter Study.
Todd JL; Weber JM; Kelly FL; Neely ML; Mulder H; Frankel CW; Nagler A; McCrae C; Newbold P; Kreindler J; Palmer SM
Chest; 2023 Sep; 164(3):670-681. PubMed ID: 37003354
[TBL] [Abstract][Full Text] [Related]
25. Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.
de Haas EC; di Pietro A; Simpson KL; Meijer C; Suurmeijer AJ; Lancashire LJ; Cummings J; de Jong S; de Vries EG; Dive C; Gietema JA
Neoplasia; 2008 Oct; 10(10):1041-8. PubMed ID: 18813353
[TBL] [Abstract][Full Text] [Related]
26. Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients.
Nord M; Schubert K; Cassel TN; Andersson O; Riise GC
Transplantation; 2002 Apr; 73(8):1264-9. PubMed ID: 11981419
[TBL] [Abstract][Full Text] [Related]
27. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
[TBL] [Abstract][Full Text] [Related]
28. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
[TBL] [Abstract][Full Text] [Related]
29. The common rejection module in chronic rejection post lung transplantation.
Sacreas A; Yang JYC; Vanaudenaerde BM; Sigdel TK; Liberto JM; Damm I; Verleden GM; Vos R; Verleden SE; Sarwal MM
PLoS One; 2018; 13(10):e0205107. PubMed ID: 30289917
[TBL] [Abstract][Full Text] [Related]
30. The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic Rejection.
Combs MP; Luth JE; Falkowski NR; Wheeler DS; Walker NM; Erb-Downward JR; Wakeam E; Sjoding MW; Dunlap DG; Admon AJ; Dickson RP; Lama VN
Am J Respir Crit Care Med; 2024 Jun; 209(11):1360-1375. PubMed ID: 38271553
[No Abstract] [Full Text] [Related]
31. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant.
Riise GC; Andersson BA; Kjellström C; Martensson G; Nilsson FN; Ryd W; Scherstén H
Eur Respir J; 1999 Nov; 14(5):1123-30. PubMed ID: 10596701
[TBL] [Abstract][Full Text] [Related]
32. Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival.
Yang JYC; Verleden SE; Zarinsefat A; Vanaudenaerde BM; Vos R; Verleden GM; Sarwal RD; Sigdel TK; Liberto JM; Damm I; Watson D; Sarwal MM
J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30781765
[TBL] [Abstract][Full Text] [Related]
33. Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation.
Suwara MI; Vanaudenaerde BM; Verleden SE; Vos R; Green NJ; Ward C; Borthwick LA; Vandermeulen E; Lordan J; Van Raemdonck DE; Corris PA; Verleden GM; Fisher AJ
Transpl Int; 2014 Aug; 27(8):857-67. PubMed ID: 24750386
[TBL] [Abstract][Full Text] [Related]
34. Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation.
Berastegui C; Gómez-Ollés S; Mendoza-Valderrey A; Pereira-Veiga T; Culebras M; Monforte V; Saez B; López-Meseguer M; Sintes-Permanyer H; Ruiz de Miguel V; Bravo C; Sacanell J; Ramon MA; Romero L; Deu M; Román A
PLoS One; 2020; 15(1):e0226488. PubMed ID: 31929536
[TBL] [Abstract][Full Text] [Related]
35. Systems prediction of chronic lung allograft dysfunction: Results and perspectives from the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction cohorts.
Pison C; Tissot A; Bernasconi E; Royer PJ; Roux A; Koutsokera A; Coiffard B; Renaud-Picard B; Le Pavec J; Mordant P; Demant X; Villeneuve T; Mornex JF; Nemska S; Frossard N; Brugière O; Siroux V; Marsland BJ; Foureau A; Botturi K; Durand E; Pellet J; Danger R; Auffray C; Brouard S; Nicod L; Magnan A;
Front Med (Lausanne); 2023; 10():1126697. PubMed ID: 36968829
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
[TBL] [Abstract][Full Text] [Related]
37. Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience.
Sugimoto S; Yamamoto H; Kurosaki T; Otani S; Okazaki M; Yamane M; Toyooka S; Oto T
Surg Today; 2019 Aug; 49(8):686-693. PubMed ID: 30790054
[TBL] [Abstract][Full Text] [Related]
38. [Development of Personalized and Targeted Preventive Therapies for Chronic Lung Allograft Dysfunction Subtypes;A Novel Strategy].
Saito T; Sato M; Taniguchi Y; Murakawa T; Keshavjee S
Kyobu Geka; 2016 Oct; 69(11):931-934. PubMed ID: 27713199
[TBL] [Abstract][Full Text] [Related]
39. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).
Sato M; Ohmori-Matsuda K; Saito T; Matsuda Y; Hwang DM; Waddell TK; Singer LG; Keshavjee S
J Heart Lung Transplant; 2013 May; 32(5):484-91. PubMed ID: 23433813
[TBL] [Abstract][Full Text] [Related]
40. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
